The Effects of Soy Protein and/or Isoflavones on Glycemic Control, Insulin Sensitivity and Cardiovascular Risk Factors-a Six Months RCT Among Postmenopausal Women

Chinese University of Hong Kong0 sitesOctober 2007

ConditionsDiabetes Cardiovascular Risk

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Diabetes
Sponsor: Chinese University of Hong Kong
Status: Completed
Last Updated: 17 years ago

Overview Investigators Eligibility Criteria Outcomes Similar Trials

Overview

Brief Summary

The investigators propose to perform a double-blind, randomized placebo-controlled trial to examine the hypothesis that soy protein with isoflavones could improve glycemic control, insulin sensitivity and decrease cardiovascular risk factors in postmenopausal women with prediabetes.

Registry

clinicaltrials.gov

Start Date

October 2007

End Date

April 2008

Last Updated

17 years ago

Study Type

Interventional

Sex

Female

Investigators

Sponsor

Chinese University of Hong Kong

Eligibility Criteria

Inclusion Criteria

•Hong Kong Chinese menopausal women aged 46-70 years with prediabetes or early untreated diabetes

Exclusion Criteria

•Women with breast, ovary or other cancers in recent 5-year
•Severe renal or liver dysfunction
•Women with androgen excess
•Current use or recent (3-month)use of any drug or treatment for glycemic control, lipid improvement, weight reduction; Subjects with known soy or milk allergy.